Andrew An
Overview
Explore the profile of Andrew An including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shemesh C, Wang Y, An A, Ding H, Chan P, Liu Q, et al.
Cancer Chemother Pharmacol
. 2024 Mar;
94(1):45-55.
PMID: 38451273
Purpose: Tiragolumab is an immunoglobulin G1 monoclonal antibody targeting the immune checkpoint T cell immunoreceptor with immunoglobulin and immunoreceptor ITIM domains. Targeting multiple immune pathways may improve anti-tumor responses. The...
2.
Greif D, Kumar M, Lighthouse J, Hum J, An A, Ding L, et al.
Dev Cell
. 2012 Sep;
23(3):482-93.
PMID: 22975322
Some of the most serious diseases involve altered size and structure of the arterial wall. Elucidating how arterial walls are built could aid understanding of these diseases, but little is...
3.
Jin D, An A, Liu J, Nakamura K, Rockson S
Lymphat Res Biol
. 2009 Mar;
7(1):47-57.
PMID: 19302023
Background: In a widely employed murine tail model of human acquired lymphedema, we have previously observed that, distal to the site of experimental lymphatic ablation, there is immunohistochemical evidence of...
4.
Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, Dua A, et al.
BioDrugs
. 2006 Dec;
20(6):363-70.
PMID: 17176124
Background: Evaluation of the efficacy of molecular treatment strategies for lymphatic vascular insufficiency requires a suitable preclinical animal model. Ideally, the model should closely replicate the untreated human disease in...
5.
Tabibiazar R, Cheung L, Han J, Swanson J, Beilhack A, An A, et al.
PLoS Med
. 2006 Jul;
3(7):e254.
PMID: 16834456
Background: Sustained lymph stagnation engenders a pathological response that is complex and not well characterized. Tissue inflammation in lymphedema may reflect either an active or passive consequence of impaired immune...
6.